Ken Fisher Veracyte, Inc. Transaction History

Fisher Asset Management, LLC

$227 Billion
Q1 2025

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Veracyte, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 848,613 shares of VCYT stock, worth $22.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

848,613

Previous 845,718 0.34%

Holding current value

$22.7 Million

Previous $33.5 Million 24.87%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$29.65 - $46.14 $85,836 - $133,575	2,895 Added 0.34%	848,613 $25.2 Million
Q4 2024 Feb 05, 2025	SELL	$31.92 - $44.4 $1.02 Million - $1.42 Million	-32,042 Reduced 3.65%	845,718 $33.5 Million
Q3 2024 Nov 12, 2024	SELL	$21.0 - $35.25 $252,987 - $424,656	-12,047 Reduced 1.35%	877,760 $29.9 Million
Q2 2024 Aug 14, 2024	BUY	$18.86 - $23.55 $138,432 - $172,857	7,340 Added 0.83%	889,807 $19.3 Million
Q1 2024 May 09, 2024	BUY	$21.0 - $29.1 $153,426 - $212,604	7,306 Added 0.83%	882,467 $19.6 Million
Q4 2023 Mar 05, 2024	BUY	$19.72 - $28.68 $13,606 - $19,789	690 Added 0.08%	875,161 $24.1 Million
Q4 2023 Feb 06, 2024	SELL	$19.72 - $28.68 $2.58 Million - $3.76 Million	-130,958 Reduced 13.03%	874,471 $24.1 Million
Q3 2023 Nov 13, 2023	SELL	$22.33 - $29.92 $22.2 Million - $29.8 Million	-995,806 Reduced 49.76%	1,005,429 $22.5 Million
Q2 2023 Dec 12, 2023	BUY	$20.96 - $26.99 $20.9 Million - $26.9 Million	995,806 Added 99.04%	2,001,235 $51 Million
Q2 2023 Aug 08, 2023	SELL	$20.96 - $26.99 $286,376 - $368,764	-13,663 Reduced 0.68%	2,001,235 $51 Million
Q1 2023 Dec 12, 2023	BUY	$20.58 - $27.89 $20.5 Million - $27.7 Million	994,612 Added 98.92%	2,000,041 $44.6 Million
Q1 2023 May 01, 2023	SELL	$20.58 - $27.89 $1.46 Million - $1.97 Million	-70,706 Reduced 3.39%	2,014,898 $44.9 Million
Q4 2022 Feb 03, 2023	BUY	$15.31 - $29.94 $5.33 Million - $10.4 Million	348,096 Added 20.03%	2,085,604 $49.5 Million
Q3 2022 Nov 08, 2022	BUY	$16.58 - $27.9 $4.35 Million - $7.32 Million	262,223 Added 17.77%	1,737,508 $28.8 Million
Q2 2022 Aug 09, 2022	BUY	$15.45 - $29.52 $5.05 Million - $9.65 Million	327,066 Added 28.48%	1,475,285 $29.4 Million
Q1 2022 May 05, 2022	SELL	$21.94 - $42.51 $469,494 - $909,671	-21,399 Reduced 1.83%	1,148,219 $31.7 Million
Q4 2021 Feb 02, 2022	BUY	$36.09 - $53.79 $7.66 Million - $11.4 Million	212,117 Added 22.15%	1,169,618 $48.2 Million
Q3 2021 Oct 26, 2021	BUY	$35.62 - $52.97 $25.4 Million - $37.8 Million	713,726 Added 292.78%	957,501 $44.5 Million
Q2 2021 Jul 27, 2021	BUY	$32.94 - $56.62 $4.37 Million - $7.51 Million	132,571 Added 119.21%	243,775 $9.75 Million
Q1 2021 Apr 27, 2021	BUY	$44.47 - $81.38 $4.95 Million - $9.05 Million	111,204 New	111,204 $5.98 Million

Others Institutions Holding VCYT

# of Institutions

306

Shares Held

79.1M

Call Options Held

15.5K

Put Options Held

16.7K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.91B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account